The Ectonucleotidases CD39 and CD73: Novel Checkpoint Inhibitor Targets

Immunological Reviews - United Kingdom
doi 10.1111/imr.12528
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Monitoring and Characterizing Soluble and Membrane-Bound Ectonucleotidases CD73 and CD39

PLoS ONE
Multidisciplinary
2019English

HPV-16 Infection Is Associated With a High Content of CD39 and CD73 Ectonucleotidases in Cervical Samples From Patients With CIN-1

Mediators of Inflammation
ImmunologyCell Biology
2019English

A9.6 Identification of New Potential Therapeutic Targets for the Treatment of Rheumatoid Arthritis: ENTPD1 (CD39) and 5NTE1 (CD73)

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2013English

On the Mechanism of Anti-Cd39 Immune Checkpoint Therapy

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2020English

CD39/CD73 and the Imbalance of Th17 Cells and Regulatory T Cells in Allergic Asthma

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2013English

The Adenosine Generating Enzymes CD39/CD73 Control Microglial Processes Ramification in the Mouse Brain

PLoS ONE
Multidisciplinary
2017English

An Exceptionally Potent Inhibitor of Human CD73

English

CD73 Immune Checkpoint Defines Regulatory NK-cells Within the Tumor Microenvironment

Journal of Clinical Investigation
Medicine
2020English

Blocking Antibodies Targeting the CD39/CD73 Immunosuppressive Pathway Unleash Immune Responses in Combination Cancer Therapies

Cell Reports
BiochemistryGeneticsMolecular Biology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy